Favorable outcomes with laparoscopic surgery for rectal cancer

Surgical Endoscopy

Volumn 24, Issue 5, 2010, Pages 1217-1218

  Liakakos, T ^a   Kopanakis, K ^a   Schizas, D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTOMOSIS LEAKAGE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DISEASE FREE SURVIVAL; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LETTER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RECTUM CANCER; RECTUM RESECTION; RECURRENT CANCER; SOLID TUMOR; SURGICAL APPROACH;

EID: 77955664134     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-009-0713-y     Document Type: Letter

References (35)

1. Kuhry E, Schwenk W, Gaupset R, Romild U, Bonjer J (2008) Long-term outcome of laparoscopic surgery for colorectal cancer: a Cochrane systematic review of randomised controlled trials. Cancer Treat Rev 34:498-504.
2. Miyajima N, Fukunaga M, Hasegawa H (2009) Results of a multicenter study of 1, 057 cases of rectal cancer treated by laparoscopic surgery. Surg Endosc 23:113-118 (Epub 19 September 2008).
3. Roukos DH (2000) Extended (D2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol 7:253-255.
4. Roukos DH, Lorenz M, Karakostas K, Paraschou P, Batsis C, Kappas AM (2001) Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanesestyle extensive surgery for Western patients: a prospective with quality control 10-year follow-up study. Br J Cancer 84:1602-1609.
5. Roukos DH, Paraschou P, Lorenz M (2000) Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol 7:719-726.
6. Roukos DH, Kappas AM (2002) Targeting the optimal extent of lymph node dissection for gastric cancer. J Surg Oncol 81:59-62.
7. Kappas AM, Fatouros M, Roukos DH (2004) Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 11:727-730.
8. Roukos DH (1998) Extended lymphadenectomy in gastric cancer: when, for whom and why. Ann R Coll Surg Engl 80:16-24.
9. Roukos DH, Hottenrott C, Lorenz M, Koutsogiorgas-Couchell S (1990) A critical evaluation of effectivity of extended lymphadenectomy in patients with carcinoma of the stomach: an analysis of early results and long-term survival. J Cancer Res Clin Oncol 116:307-311.
10. Roukos DH (2002) Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 9:220-221.
11. Kappas AM, Roukos DH (2002) Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol 9(9):828-830.
12. Roukos DH, Hottenrott C, Encke A, Baltogiannis G, Casioumis D (1994) Primary gastric lymphomas: a clinicopathologic study with literature review. Surg Oncol 3:115-125.
13. Roukos DH (2004) Early-stage gastric cancer: a highly treatable disease. Ann Surg Oncol 11:127-129.
14. Liakakos T, Roukos DH (2008) More controversy than ever: challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol 15:956-960.
15. Roukos DH, Kappas AM, Agnantis NJ (2003) Perspectives and risks of breast-conservation therapy for breast cancer. Ann Surg Oncol 10:718-721.
16. Fatouros M, Roukos DH, Arampatzis I, Sotiriadis A, Paraskevaidis E, Kappas AM(2005) Factors increasing local recurrence in breastconserving surgery. Expert Rev Anticancer Ther 5:737-745.
17. Roukos DH (2008) Linking contralateral breast cancer with genetics. Radiother Oncol 86:139-141.
18. Roukos DH (2009) Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer. Ann Surg Oncol 16:795-798.
19. Fatouros M, Baltogiannis G, Roukos DH (2008) The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol 15:21-33.
20. Wood LD, Parsons DW, Jones S (2007) The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113.
21. Roukos DH, Ziogas D (2009) Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the "Gordian knot"? Ann Surg Oncol 16:774-775.
22. Roukos DH (2008) Breast-cancer stromal cells with TP53 mutations. N Engl J Med 358:1636.
23. Roukos DH (2009) Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn 9:1-6.
24. Roukos DH (2009) Genome-wide association studies: how predictable is a person's cancer risk? Expert Rev Anticancer Ther 9:389-392.
25. Roukos DH (2009) Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann Surg Oncol 16:772-773.
26. Roukos DH (2008) HER2 and response to paclitaxel in nodepositive breast cancer. N Engl J Med 358:197.
27. Roukos DH (2009) Mea culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine. Expert Rev Mol Diagn 9:217-221.
28. Roukos DH (2009) Personalized cancer diagnostics and therapeutics. Expert Rev Mol Diagn 9:227-229.
29. Roukos DH (2009) Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer. J Clin Oncol 27:1337-1338.
30. Roukos DH (2009) Radiation therapy for breast cancer. N Engl J Med 360:1362-1363.
31. Roukos DH (2008) Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery. Expert Rev Mol Diagn 8:587-597.
32. Ziogas D, Baltogiannis G, Fatouros M, Roukos DH (2008) Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg 247:714-715.
33. Ziogas D, Roukos DH (2009) Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol 16(7):1771-1782.
34. Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 24(6):1067-1068.
35. Ziogas D, Roukos DH (2009) CDH1 testing: can it predict the prophylactic or therapeutic nature of total gastrectomy in hereditary diffuse gastric cancer? Ann Surg Oncol 16(10):2678-2681.